Summit Wealth Group (Colorado)’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Summit Wealth Group (Colorado)'s BIIB Position: Q4 2025 in Review
Summit Wealth Group (Colorado) sold out of Biogen (BIIB) in Q4 2025, closing a stake of 2,146 shares — an estimated $552K sold.
Summit Wealth Group (Colorado) first reported a position in BIIB in Q3 2025 and held it in 1 quarter. The position peaked at $552K in Q3 2025. 1,001 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.
- Summit Wealth Group (Colorado) reported no remaining Biogen position as of Q4 2025 after selling out during the quarter.
- Summit Wealth Group (Colorado) sold 2,146 Biogen shares in Q4 2025, an estimated $552K.
- Summit Wealth Group (Colorado) first reported a position in Biogen in Q3 2025 and held it in 1 quarter.
- Summit Wealth Group (Colorado)'s Biogen position peaked at $552K in Q3 2025.
- 1,001 funds tracked by Wall St. Rank held Biogen as of Q4 2025.
Based on Summit Wealth Group (Colorado)'s 13F filing for Q4 2025, filed 4 Feb 2026.